Matches in SemOpenAlex for { <https://semopenalex.org/work/W1993306590> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W1993306590 abstract "Background DuoResp Spiromax ® (Teva Pharmaceuticals) is a dry-powder inhaler designed to deliver budesonide and formoterol fumarate (BF Spiromax ® ) with maximum ease of use. Pharmacokinetic studies have shown bioequivalence of BF Turbuhaler ® . This study compared the efficacy and safety of these devices in patients with asthma. Methods This was a 12-week, multicentre, double-blind, randomised, controlled trial (N=605). Eligible patients (≥12 years old) had persistent asthma with FEV 1 40–85% predicted, had used a SABA and ICS for ≥8 weeks before screening and were maintained on stable-dose ICS for 4 weeks. The primary objective was to demonstrate non-inferiority of twice-daily BF Spiromax ® 160/4.5mcg to BF Turbuhaler ® 200/6mcg, with respect to change from baseline in weekly average of daily trough morning PEF. Results This analysis was based on the per protocol population (N=290 and N=284 for BF Spiromax ® and BF Turbuhaler ® groups, respectively). The least squares mean change from baseline to Week 12 in morning PEF was 18.8 L/min with BF Spiromax ® and 21.796 L/min with BF Turbuhaler ® . Non-inferiority of BF Spiromax ® vs BF Turbuhaler ® was demonstrated, as the lower limit of the 95% two-sided CI (–9.02 L/min) is greater than –15 L/min. Similarly, no significant between-group differences were observed in secondary efficacy endpoints. Both devices were well tolerated, with no significant differences in the incidence of adverse events or asthma exacerbations. Conclusions This study has demonstrated the non-inferiority of BF Spiromax ® vs BF Turbuhaler ® in adults and adolescents with asthma. Further data are required to confirm whether BF Spiromax ® can be used as an alternative to BF Turbuhaler ® in other indications. Sponsor: Teva Pharmaceuticals." @default.
- W1993306590 created "2016-06-24" @default.
- W1993306590 creator A5027794430 @default.
- W1993306590 creator A5029639628 @default.
- W1993306590 creator A5037731656 @default.
- W1993306590 creator A5075950948 @default.
- W1993306590 date "2014-11-10" @default.
- W1993306590 modified "2023-09-23" @default.
- W1993306590 title "P227 Efficacy And Safety Of Budesonide-formoterol (bf) Spiromax(R) In Adults And Adolescents With Asthma: Randomised Comparison With Bf Turbuhaler(R)" @default.
- W1993306590 doi "https://doi.org/10.1136/thoraxjnl-2014-206260.355" @default.
- W1993306590 hasPublicationYear "2014" @default.
- W1993306590 type Work @default.
- W1993306590 sameAs 1993306590 @default.
- W1993306590 citedByCount "3" @default.
- W1993306590 countsByYear W19933065902015 @default.
- W1993306590 countsByYear W19933065902016 @default.
- W1993306590 crossrefType "journal-article" @default.
- W1993306590 hasAuthorship W1993306590A5027794430 @default.
- W1993306590 hasAuthorship W1993306590A5029639628 @default.
- W1993306590 hasAuthorship W1993306590A5037731656 @default.
- W1993306590 hasAuthorship W1993306590A5075950948 @default.
- W1993306590 hasBestOaLocation W19933065901 @default.
- W1993306590 hasConcept C112705442 @default.
- W1993306590 hasConcept C126322002 @default.
- W1993306590 hasConcept C19720800 @default.
- W1993306590 hasConcept C197934379 @default.
- W1993306590 hasConcept C2776042228 @default.
- W1993306590 hasConcept C2776136866 @default.
- W1993306590 hasConcept C2777419714 @default.
- W1993306590 hasConcept C2778375690 @default.
- W1993306590 hasConcept C2779871671 @default.
- W1993306590 hasConcept C2780261241 @default.
- W1993306590 hasConcept C2908647359 @default.
- W1993306590 hasConcept C42404028 @default.
- W1993306590 hasConcept C71924100 @default.
- W1993306590 hasConcept C99454951 @default.
- W1993306590 hasConceptScore W1993306590C112705442 @default.
- W1993306590 hasConceptScore W1993306590C126322002 @default.
- W1993306590 hasConceptScore W1993306590C19720800 @default.
- W1993306590 hasConceptScore W1993306590C197934379 @default.
- W1993306590 hasConceptScore W1993306590C2776042228 @default.
- W1993306590 hasConceptScore W1993306590C2776136866 @default.
- W1993306590 hasConceptScore W1993306590C2777419714 @default.
- W1993306590 hasConceptScore W1993306590C2778375690 @default.
- W1993306590 hasConceptScore W1993306590C2779871671 @default.
- W1993306590 hasConceptScore W1993306590C2780261241 @default.
- W1993306590 hasConceptScore W1993306590C2908647359 @default.
- W1993306590 hasConceptScore W1993306590C42404028 @default.
- W1993306590 hasConceptScore W1993306590C71924100 @default.
- W1993306590 hasConceptScore W1993306590C99454951 @default.
- W1993306590 hasLocation W19933065901 @default.
- W1993306590 hasLocation W19933065902 @default.
- W1993306590 hasOpenAccess W1993306590 @default.
- W1993306590 hasPrimaryLocation W19933065901 @default.
- W1993306590 hasRelatedWork W1969735103 @default.
- W1993306590 hasRelatedWork W1979052047 @default.
- W1993306590 hasRelatedWork W2004371282 @default.
- W1993306590 hasRelatedWork W2024458062 @default.
- W1993306590 hasRelatedWork W2084811485 @default.
- W1993306590 hasRelatedWork W2103629928 @default.
- W1993306590 hasRelatedWork W2144802986 @default.
- W1993306590 hasRelatedWork W2299561706 @default.
- W1993306590 hasRelatedWork W2342052575 @default.
- W1993306590 hasRelatedWork W2395668149 @default.
- W1993306590 hasRelatedWork W2460328214 @default.
- W1993306590 hasRelatedWork W2517037866 @default.
- W1993306590 hasRelatedWork W2987941879 @default.
- W1993306590 hasRelatedWork W2988347799 @default.
- W1993306590 hasRelatedWork W3027296839 @default.
- W1993306590 hasRelatedWork W3084377968 @default.
- W1993306590 hasRelatedWork W3205373988 @default.
- W1993306590 hasRelatedWork W1821139876 @default.
- W1993306590 hasRelatedWork W1910660067 @default.
- W1993306590 hasRelatedWork W1962858305 @default.
- W1993306590 isParatext "false" @default.
- W1993306590 isRetracted "false" @default.
- W1993306590 magId "1993306590" @default.
- W1993306590 workType "article" @default.